Numerous clinical trials spanning phase 1 through phase 4 evaluate etoposide across various recruitment statuses, including active, recruiting, and completed protocols. Sponsored by academic medical centers, government organizations such as the National Cancer Institute, and biopharmaceutical companies, these studies investigate etoposide—frequently in combination chemo-immunotherapy regimens—for advanced solid and hematological malignancies, particularly small cell lung cancer, neuroendocrine carcinomas, Merkel cell carcinoma, breast cancer, and hematologic cancers such as NK/T-cell lymphomas and leukemias.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT04681417 | RECRUITING | Retinoblastoma |
Institut Curie |
2021-03-25 | PHASE2; PHASE3 |
| NCT02106988 | ACTIVE_NOT_RECRUITING | Lymphoma |
M.D. Anderson Cancer Center |
2015-01-16 | PHASE2 |
| NCT07321912 | RECRUITING | Osteosarcoma; Ewing Sarcoma |
Milton S. Hershey Medical Center |
2026-06-05 | PHASE2 |
| NCT07662928 | NOT_YET_RECRUITING | Adult Burkitt Lymphoma |
AIDS Malignancy Consortium |
2026-09-17 | PHASE2 |
| NCT05675410 | RECRUITING | Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 |
National Cancer Institute (NCI) |
2023-05-11 | PHASE3 |
| NCT05605899 | ACTIVE_NOT_RECRUITING | High-risk Large B-cell Lymphoma (LBCL) |
Kite, A Gilead Company |
2023-02-10 | PHASE3 |
| NCT06401330 | RECRUITING | Stage I Mixed Cell Type Kidney Wilms Tumor; Stage II Mixed Cell Type Kidney Wilms Tumor; Stage III Mixed Cell Type Kidney Wilms Tumor; Stage IV Mixed Cell Type Kidney Wilms Tumor |
Children's Oncology Group |
2025-04-15 | PHASE3 |
| NCT07227584 | RECRUITING | Acute Lymphoblastic Leukemia; Philadelphia Chromosome-Negative Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia (ALL); Leukemia |
Dana-Farber Cancer Institute |
2026-04-03 | PHASE2 |
| NCT07796100 | NOT_YET_RECRUITING | Extensive-Stage Small Cell Lung Cancer |
Zai Lab (Shanghai) Co., Ltd. |
2026-12-31 | PHASE3 |
| NCT07141771 | NOT_YET_RECRUITING | SCLC, Extensive Stage |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2025-12-31 | PHASE1; PHASE2 |
| NCT01356290 | RECRUITING | Medulloblastoma Recurrent; Ependymoma Recurrent; ATRT Recurrent; Rare CNS Tumor Recurrent |
Medical University of Vienna |
2014-04 | PHASE2 |
| NCT04684368 | RECRUITING | Central Nervous System Nongerminomatous Germ Cell Tumor; Choriocarcinoma; Embryonal Carcinoma; Immature Teratoma; Malignant Teratoma; Mixed Germ Cell Tumor; Pineal Region Germ Cell Tumor; Pineal Region Immature Teratoma; Pineal Region Yolk Sac Tumor; Suprasellar Germ Cell Tumor |
Children's Oncology Group |
2021-07-13 | PHASE2 |
| NCT07502300 | RECRUITING | Extensive-stage Small-cell Lung Cancer |
Sichuan Baili Pharmaceutical Co., Ltd. |
2026-06-15 | PHASE3 |
| NCT04325425 | RECRUITING | Neuroendocrine Carcinoma |
Centre Hospitalier Universitaire Dijon |
2020-09-01 | PHASE2 |
| NCT07055581 | RECRUITING | Small Cell Lung Cancer Limited Stage |
Qian Chu |
2026-02-24 | PHASE2 |
| NCT06528496 | RECRUITING | High-risk Neuroblastoma; Neuroblastoma; Childhood Neuroblastoma |
Memorial Sloan Kettering Cancer Center |
2024-07-22 | PHASE2 |
| NCT04293562 | RECRUITING | Acute Myeloid Leukemia |
Children's Oncology Group |
2020-07-21 | PHASE3 |
| NCT06436144 | NOT_YET_RECRUITING | Non Small Cell Lung Cancer; EGFR Gene Mutation; Non Small Cell Lung Cancer Stage IIIB; Non-small Cell Lung Cancer Stage IV |
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University |
2024-06 | PHASE2 |
| NCT07802821 | NOT_YET_RECRUITING | Extensive-stage Small Cell Lung Cancer |
Qilu Pharmaceutical Co., Ltd. |
2026-10-15 | PHASE3 |
| NCT04469530 | RECRUITING | Solid Tumor |
Emory University |
2020-09-16 | PHASE2 |
| NCT07005128 | RECRUITING | Small-cell Lung Cancer; Extensive Stage Small-cell Lung Cancer |
Amgen |
2025-08-18 | PHASE3 |
| NCT06769126 | RECRUITING | Extensive Stage Lung Small Cell Carcinoma; Lung Small Cell Carcinoma, A Subtype; Lung Small Cell Carcinoma, I Subtype; Lung Small Cell Carcinoma, N Subtype; Lung Small Cell Carcinoma, P Subtype |
SWOG Cancer Research Network |
2025-11-06 | PHASE2 |
| NCT06792253 | RECRUITING | Relapsed/Refractory Diffuse Large B-Cell Lymphoma |
BeBetter Med Inc |
2025-01-06 | PHASE3 |
| NCT06552559 | RECRUITING | B-cell Lymphoma Recurrent; B-cell Lymphoma Refractory; CNS Metastases |
Samsung Medical Center |
2024-05-01 | PHASE1; PHASE2 |
| NCT07258680 | ENROLLING_BY_INVITATION | Peripheral T-cell Lymphoma |
N.N. Petrov National Medical Research Center of Oncology |
2013-10 | PHASE3 |
| NCT05058651 | SUSPENDED | Advanced Extrapulmonary Neuroendocrine Carcinoma; Metastatic Extrapulmonary Neuroendocrine Carcinoma; Recurrent Extrapulmonary Neuroendocrine Carcinoma; Unresectable Extrapulmonary Neuroendocrine Carcinoma |
National Cancer Institute (NCI) |
2022-06-28 | PHASE2; PHASE3 |
| NCT06393816 | RECRUITING | Large Cell Neuroendocrine Carcinoma of the Lung |
Centre Leon Berard |
2024-06-13 | PHASE2 |
| NCT06663098 | RECRUITING | Extensive Stage Small Cell Lung Cancer (ES-SCLC) |
Gruppo Oncologico Italiano di Ricerca Clinica |
2025-01-24 | PHASE2 |
| NCT05361395 | ACTIVE_NOT_RECRUITING | Extensive Stage Small Cell Lung Cancer |
Amgen |
2022-08-24 | PHASE1 |
| NCT07224100 | RECRUITING | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; B Lymphoblastic Leukemia/Lymphoma With t(9;22)(q34.1;q11.2); BCR-ABL1; Lymphoblastic Lymphoma |
University of Washington |
2026-03-30 | PHASE2 |
| NCT06905509 | RECRUITING | Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements; Recurrent High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements; Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified; Recurrent Nodal Marginal Zone Lymphoma; Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Refractory High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements; Refractory High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements; Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified; Refractory Nodal Marginal Zone Lymphoma; Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma |
University of California, Davis |
2025-07-31 | PHASE2 |
| NCT07336147 | RECRUITING | Female |
Chang Gung Memorial Hospital |
2025-12-22 | PHASE2 |
| NCT05389423 | RECRUITING | Diffuse Large Cell Lymphoma; Non-Hodgkin Lymphoma; Burkitt Lymphoma; Plasmablastic Lymphoma; B-Cell Neoplasm |
National Cancer Institute (NCI) |
2023-06-27 | PHASE1 |
| NCT06262438 | RECRUITING | Acute Myeloid Leukemia in Children |
Princess Maxima Center for Pediatric Oncology |
2024-02-06 | PHASE2 |
| NCT03984448 | ACTIVE_NOT_RECRUITING | Diffuse Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Double-Expressor Lymphoma; EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Neoplastic Cells With Double Expression of MYC and BCL2 Proteins Present; Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma |
National Cancer Institute (NCI) |
2019-10-22 | PHASE2; PHASE3 |
| NCT05504291 | RECRUITING | Bilateral Retinoblastoma; Childhood Intraocular Retinoblastoma; Group D Retinoblastoma; Stage I Retinoblastoma; Unilateral Retinoblastoma |
Children's Oncology Group |
2022-11-04 | PHASE2 |
| NCT07525466 | RECRUITING | Extranodal NK T Cell Lymphoma; Hemophagocytic Lymphohistiocytosis (HLH) |
Beijing Tongren Hospital |
2026-04-01 | PHASE1; PHASE2 |
| NCT05106296 | RECRUITING | Ependymoma; Medulloblastoma; Glioblastoma; Primary Brain Tumor |
Theodore S. Johnson |
2022-02-08 | PHASE1 |
| NCT05142696 | ACTIVE_NOT_RECRUITING | Extensive Stage Small Cell Lung Cancer |
Novartis Pharmaceuticals |
2022-07-13 | PHASE1; PHASE2 |
| NCT06771622 | ACTIVE_NOT_RECRUITING | Solid Cancer |
FBD Biologics Limited |
2025-03-13 | PHASE1; PHASE2 |
| NCT06464068 | RECRUITING | Extrapulmonary Small Cell Carcinoma |
Gruppo Oncologico Italiano di Ricerca Clinica |
2024-01-16 | PHASE2 |
| NCT03719105 | RECRUITING | NK-Cell Lymphoma; NK-Cell Leukemia; Peripheral T Cell Lymphoma |
New York Medical College |
2019-03-01 | EARLY_PHASE1 |
| NCT07258147 | NOT_YET_RECRUITING | Lung Cancer (SCLC) |
Sichuan University |
2026-10-31 | PHASE2 |
| NCT05253495 | RECRUITING | Non-hodgkin Lymphoma; Hodgkin Lymphoma |
New York Medical College |
2022-02-01 | PHASE2 |
| NCT07349225 | NOT_YET_RECRUITING | ES-SCLC |
The Second Affiliated Hospital of Dalian Medical University |
2026-01-31 | PHASE2 |
| NCT07728955 | NOT_YET_RECRUITING | Small Cell Lung Cancer ( SCLC ) |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2026-08-01 | PHASE3 |
| NCT07001995 | NOT_YET_RECRUITING | Small Cell Lung Cancer; Non Small Cell Lung Cancer; Non Small Cell Lung Cancer NSCLC |
Hunan Province Tumor Hospital |
2026-05-01 | PHASE2 |
| NCT05955170 | RECRUITING | HER2-positive Breast Cancer |
Institut Curie |
2023-12-19 | PHASE2 |
| NCT07245446 | RECRUITING | Extensive-stage Small Cell Lung Cancer (ES-SCLC) |
Akeso |
2025-10-29 | PHASE2 |
| NCT00871013 | ACTIVE_NOT_RECRUITING | Myeloma |
University of Arkansas |
2009-03 | PHASE2 |
| NCT07172412 | NOT_YET_RECRUITING | Extensive Stage Lung Small Cell Cancer |
Tianjin Medical University Cancer Institute and Hospital |
2025-11 | PHASE2 |
| NCT05652686 | RECRUITING | Small Cell Lung Cancer (SCLC); Large Cell Neuroendocrine Cancer (LCNEC); Neuroendocrine Prostate Cancer (NEPC); Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC); Neuroendocrine Carcinomas (NEC); Extrapulmonary Neuroendocrine Carcinoma (EP-NEC) |
Phanes Therapeutics |
2023-09-05 | PHASE1; PHASE2 |
| NCT06086288 | NOT_YET_RECRUITING | Merkel Cell Carcinoma |
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano |
2023-11 | PHASE2 |
| NCT02861573 | ACTIVE_NOT_RECRUITING | Metastatic Castration-Resistant Prostate Cancer |
Merck Sharp & Dohme LLC |
2016-11-17 | PHASE1; PHASE2 |
| NCT05796089 | ACTIVE_NOT_RECRUITING | Extensive-Stage Small-Cell Lung Cancer |
Trans Tasman Radiation Oncology Group |
2022-01-01 | PHASE2 |
| NCT07155122 | NOT_YET_RECRUITING | Small-Cell Carcinoma of the Esophageal |
Fujian Cancer Hospital |
2025-09-01 | PHASE2 |
| NCT07009457 | ACTIVE_NOT_RECRUITING | Widespread Small Cell Lung Cancer |
Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
2025-06-16 | PHASE1 |
| NCT07061535 | RECRUITING | Extensive-stage Small Cell Lung Cancer (ES-SCLC); Extensive Stage Lung Small Cell Cancer; Extensive-Stage Small-Cell Lung Cancer; Extensive Disease Small Cell Lung Cancer |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2025-07-30 | PHASE2 |
| NCT03136146 | RECRUITING | Recurrent Acute Lymphoblastic Leukemia; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Burkitt Leukemia; Recurrent Burkitt Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; Refractory Acute Lymphoblastic Leukemia; Refractory Burkitt Leukemia; Refractory Burkitt Lymphoma; Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; Refractory Lymphoblastic Lymphoma |
M.D. Anderson Cancer Center |
2017-08-09 | PHASE2 |
| NCT00572169 | ACTIVE_NOT_RECRUITING | Multiple Myeloma |
University of Arkansas |
2006-11 | PHASE3 |
| NCT04322318 | RECRUITING | Anaplastic Kidney Wilms Tumor; Recurrent Kidney Wilms Tumor; Stage II Kidney Wilms Tumor; Stage III Kidney Wilms Tumor; Stage IV Kidney Wilms Tumor |
Children's Oncology Group |
2020-10-19 | PHASE2 |
| NCT04301076 | RECRUITING | Acute Adult T-Cell Leukemia/Lymphoma; Adult T-Cell Leukemia/Lymphoma; Chronic Adult T-Cell Leukemia/Lymphoma; HTLV-1 Infection |
National Cancer Institute (NCI) |
2021-08-31 | PHASE1 |
| NCT03567642 | ACTIVE_NOT_RECRUITING | Lung Cancer |
Memorial Sloan Kettering Cancer Center |
2018-06-12 | PHASE1 |
| NCT01873326 | ACTIVE_NOT_RECRUITING | Germ Cell Tumors |
Memorial Sloan Kettering Cancer Center |
2013-06 | PHASE2 |
| NCT04803201 | RECRUITING | Angioimmunoblastic T-cell Lymphoma; Enteropathy-Associated T-Cell Lymphoma; Follicular T-Cell Lymphoma; Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma; Nodal Peripheral T-Cell Lymphoma With TFH Phenotype; Peripheral T-Cell Lymphoma, Not Otherwise Specified |
Alliance for Clinical Trials in Oncology |
2021-10-08 | PHASE2 |
| NCT02341989 | ACTIVE_NOT_RECRUITING | Testicular Neoplasms; Seminoma |
St. Olavs Hospital |
2015-04-08 | PHASE3 |
| NCT06375109 | NOT_YET_RECRUITING | Limited-stage Small-cell Lung Cancer |
Beijing Chest Hospital, Capital Medical University |
2024-04-16 | PHASE2 |
| NCT07081022 | ACTIVE_NOT_RECRUITING | B-cell Non-Hodgkin's Lymphoma |
Shanghai Junshi Bioscience Co., Ltd. |
2025-08-17 | PHASE2 |
| NCT03533582 | ACTIVE_NOT_RECRUITING | Childhood Hepatocellular Carcinoma; Childhood Malignant Liver Neoplasm; Fibrolamellar Carcinoma; Hepatoblastoma; Hepatocellular Malignant Neoplasm, Not Otherwise Specified |
Children's Oncology Group |
2018-05-24 | PHASE3 |
| NCT06255210 | RECRUITING | Olfactory Neuroblastoma |
Hongmeng Yu |
2024-03-01 | PHASE2 |
| NCT03755804 | ACTIVE_NOT_RECRUITING | Hodgkin Lymphoma |
St. Jude Children's Research Hospital |
2018-12-12 | PHASE2 |
| NCT04699838 | ACTIVE_NOT_RECRUITING | Extensive Stage Small Cell Lung Cancer |
Muhammad Furqan |
2021-04-20 | PHASE2 |
| NCT06477523 | ACTIVE_NOT_RECRUITING | SCLC, Extensive Stage |
Sichuan University |
2024-05-16 | PHASE1; PHASE2 |
| NCT04602533 | ACTIVE_NOT_RECRUITING | Small Cell Lung Cancer Limited Stage |
Michael Hopp |
2020-12-21 | PHASE2 |
| NCT04638790 | RECRUITING | Hodgkin Lymphoma, Adult |
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia |
2020-02-01 | PHASE3 |
| NCT05681260 | RECRUITING | T-cell Lymphoblastic Lymphoma |
Children's Cancer Group, China |
2023-02-06 | PHASE3 |
| NCT06536868 | RECRUITING | Extensive-stage Small-cell Lung Cancer |
Second Hospital of Shanxi Medical University |
2024-08-01 | PHASE2 |
| NCT07381829 | RECRUITING | Advanced Solid Tumor Cancer |
HC Biopharma Inc. |
2025-10-27 | PHASE1 |
| NCT06157827 | RECRUITING | Advanced Neuroendocrine Carcinoma |
Nanjing Leads Biolabs Co.,Ltd |
2023-12-08 | PHASE1; PHASE2 |
| NCT06520176 | RECRUITING | Multiple Myeloma; Hematopoietic Stem Cell Mobilization |
The Affiliated People's Hospital of Ningbo University |
2024-08 | PHASE3 |
| NCT07136285 | RECRUITING | SCLC, Extensive Stage |
Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd. |
2023-07-24 | PHASE1; PHASE2 |
| NCT05590572 | NOT_YET_RECRUITING | Osteosarcoma |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2023-01 | PHASE1; PHASE2 |
| NCT02393157 | RECRUITING | Non-Hodgkin Lymphoma; Burkitt Lymphoma; Diffuse Large B-Cell Lymphoma; Primary Mediastinal B-cell Lymphoma; CD20+ Lymphoblastic Lymphoma; Follicular Lymphoma, Grade III |
New York Medical College |
2015-08-21 | PHASE2 |
| NCT03467360 | RECRUITING | Small Cell Lung Cancer |
Centre Antoine Lacassagne |
2019-08-02 | PHASE1 |
| NCT03117751 | ACTIVE_NOT_RECRUITING | Acute Lymphoblastic Leukemia; Acute Lymphoblastic Lymphoma |
St. Jude Children's Research Hospital |
2017-03-29 | PHASE2; PHASE3 |
| NCT02203526 | ACTIVE_NOT_RECRUITING | Primary Central Nervous System Lymphoma |
National Cancer Institute (NCI) |
2014-08-14 | PHASE1 |
| NCT06419179 | ENROLLING_BY_INVITATION | Small Cell Lung Carcinoma |
University of Cologne |
2024-10-09 | PHASE2 |
| NCT07361133 | NOT_YET_RECRUITING | Squamous Cell Carcinoma; Advanced Head and Neck Cancer |
National Cancer Institute, Egypt |
2026-04 | PHASE2 |
| NCT06756152 | RECRUITING | Biphenotypic Acute Leukemia; Acute Lymphoblastic Leukemia; Myeloblastic Leukemia; Bilinear Leukemia; Malignant Lymphoma, Non-Hodgkin; Myelodysplastic Syndrome |
Federal Research Institute of Pediatric Hematology, Oncology and Immunology |
2024-07-10 | PHASE2; PHASE3 |
| NCT05353257 | ACTIVE_NOT_RECRUITING | Limited-Stage Small Cell Lung Cancer |
Shanghai Henlius Biotech |
2022-05-17 | PHASE3 |
| NCT06911606 | RECRUITING | SCLC, Limited Stage |
Guangdong Provincial People's Hospital |
2024-05-22 | PHASE2 |
| NCT05298423 | COMPLETED | Carcinoma, Non-Small-Cell Lung |
Merck Sharp & Dohme LLC |
2022-05-03 | PHASE3 |
| NCT04602377 | RECRUITING | Small Cell Ovarian Carcinoma |
ARCAGY/ GINECO GROUP |
2021-08-04 | PHASE2 |
| NCT05221645 | ACTIVE_NOT_RECRUITING | Diffuse Large B Cell Lymphoma |
University of Southampton |
2022-06-27 | PHASE2 |
| NCT05453500 | ACTIVE_NOT_RECRUITING | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative |
University of Washington |
2023-03-27 | PHASE2 |
| NCT05936086 | RECRUITING | Hemophagocytic Syndrome |
shifeng Lou |
2023-04-20 | |
| NCT06897579 | TERMINATED | Extensive Stage Small Cell Lung Cancer |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2025-04-07 | PHASE2 |
| NCT04824352 | SUSPENDED | Effect of Drug; Toxicity, Drug |
Peking University People's Hospital |
2021-04-01 | PHASE2 |
| NCT05294055 | RECRUITING | Multiple Myeloma; Lymphoma |
Institute of Hematology & Blood Diseases Hospital, China |
2022-04-26 | PHASE2 |
| NCT05815160 | TERMINATED | Small Cell Lung Cancer Recurrent |
Debiopharm International SA |
2023-05-02 | PHASE1 |
| NCT05468489 | ACTIVE_NOT_RECRUITING | Extensive Stage Small Cell Lung Cancer |
Shanghai Henlius Biotech |
2022-11-18 | PHASE3 |
| NCT03420963 | TERMINATED | Recurrent Cutaneous Melanoma; Recurrent Lip and Oral Cavity Carcinoma; Recurrent Malignant Endocrine Neoplasm; Recurrent Malignant Female Reproductive System Neoplasm; Recurrent Malignant Male Reproductive System Neoplasm; Recurrent Malignant Mesothelioma; Recurrent Malignant Neoplasm of Multiple Primary Sites; Recurrent Malignant Oral Neoplasm; Recurrent Malignant Pharyngeal Neoplasm; Recurrent Malignant Skin Neoplasm; Recurrent Malignant Soft Tissue Neoplasm; Recurrent Malignant Solid Neoplasm; Recurrent Malignant Thyroid Gland Neoplasm; Recurrent Malignant Urinary System Neoplasm; Refractory Cutaneous Melanoma; Refractory Malignant Bone Neoplasm; Refractory Malignant Endocrine Neoplasm; Refractory Malignant Female Reproductive System Neoplasm; Refractory Malignant Male Reproductive System Neoplasm; Refractory Malignant Mesothelioma; Refractory Malignant Neoplasm of Multiple Primary Sites; Refractory Malignant Oral Neoplasm; Refractory Malignant Pharyngeal Neoplasm; Refractory Malignant Skin Neoplasm; Refractory Malignant Soft Tissue Neoplasm; Refractory Malignant Solid Neoplasm; Refractory Malignant Thyroid Gland Neoplasm; Refractory Malignant Urinary System Neoplasm |
M.D. Anderson Cancer Center |
2018-08-31 | PHASE1 |
| NCT06485544 | RECRUITING | Small Cell Lung Cancer (SCLC) |
Tang-Du Hospital |
2024-07-01 | PHASE2 |
| NCT05466318 | UNKNOWN | Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell |
Sichuan University |
2022-07-01 | PHASE3 |
| NCT00716066 | ACTIVE_NOT_RECRUITING | Autoimmune Disease; Neurologic Autoimmune Disease; Autologous Transplant Autoimmune; Multiple Sclerosis Transplant; MS Stem Cell Transplant; Multiple Sclerosis Stem Cell Transplant; Stiff Person Syndrome; HCT for Neurologic Autoimmune Disorders; CIDP Transplant; Myasthenia Gravis Transplant; Autoimmune Nervous System Disorder; Central Nervous System Vasculitis; Cerebellar Degeneration; Chronic Inflammatory Demyelinating Polyneuropathy; Lambert Eaton Myasthenic Syndrome; Myasthenia Gravis; Neuromyelitis Optica; Opsoclonus Myoclonus Syndrome; Rasmussen Subacute Encephalitis |
Fred Hutchinson Cancer Center |
2008-06 | PHASE2 |
| NCT04177004 | ACTIVE_NOT_RECRUITING | Allogeneic Hematopoietic Stem Cell Transplant Recipient; Hematopoietic and Lymphoid Cell Neoplasm |
City of Hope Medical Center |
2021-04-30 | PHASE1 |
| NCT04833114 | COMPLETED | Relapsed Diffuse Large B-cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma |
GWT-TUD GmbH |
2021-04-30 | PHASE3 |
| NCT03582475 | ACTIVE_NOT_RECRUITING | Bladder Small Cell Neuroendocrine Carcinoma; Castration-Resistant Prostate Carcinoma; Metastatic Bladder Urothelial Carcinoma; Metastatic Urethral Urothelial Carcinoma; Prostate Carcinoma Metastatic in the Bone; Prostate Neuroendocrine Neoplasm; Prostate Small Cell Carcinoma; Stage III Bladder Cancer American Joint Committee on Cancer ( AJCC) v8; Stage III Prostate Cancer AJCC v8; Stage III Urethral Cancer AJCC v8; Stage IV Bladder Cancer AJCC v8; Stage IV Prostate Cancer AJCC v8; Stage IV Urethral Cancer AJCC v8; Stage IVA Bladder Cancer AJCC v8; Stage IVB Bladder Cancer AJCC v8; Ureter Small Cell Carcinoma; Urothelial Carcinoma |
Jonsson Comprehensive Cancer Center |
2019-01-11 | PHASE1 |
| NCT06857747 | UNKNOWN | Breast Cancer |
QIAO LI |
2025-03-01 | |
| NCT06418594 | RECRUITING | HER2-negative Breast Cancer Brain Metastases |
Beijing 302 Hospital |
2024-10-10 | PHASE2 |
| NCT04551131 | ACTIVE_NOT_RECRUITING | Hemophagocytic Lymphohistiocytosis |
St. Jude Children's Research Hospital |
2021-07-13 | PHASE1; PHASE2 |
| NCT06164327 | UNKNOWN | Relapsed/Refractory Diffuse Large B-Cell Lymphoma |
BeBetter Med Inc |
2023-12-01 | PHASE1 |
| NCT05364424 | COMPLETED | Diffuse Large B-Cell Lymphoma (DLBCL) |
Hoffmann-La Roche |
2022-11-04 | PHASE1 |
| NCT06049966 | COMPLETED | Large Cell Neuroendocrine Carcinoma of the Lung |
Oncology Center of Biochemical Education And Research |
2019-11-01 | PHASE1 |
| NCT04501718 | RECRUITING | Recurrent Medulloblastoma |
Beijing Sanbo Brain Hospital |
2020-10-28 | PHASE2 |
| NCT04924101 | COMPLETED | Small Cell Lung Cancer |
Merck Sharp & Dohme LLC |
2021-07-15 | PHASE2 |
| NCT05882630 | UNKNOWN | Small Cell Lung Cancer |
Fujian Cancer Hospital |
2023-06-01 | PHASE1; PHASE2 |
| NCT06140407 | TERMINATED | Limited Stage Lung Small Cell Carcinoma; Stage I Lung Cancer; Stage II Lung Cancer; Stage III Lung Cancer |
Vanderbilt-Ingram Cancer Center |
2024-02-14 | PHASE2 |
| NCT04702880 | COMPLETED | Extensive-stage Small Cell Lung Cancer |
Bristol-Myers Squibb |
2021-03-17 | PHASE2 |
| NCT04691063 | UNKNOWN | Small-cell Lung Cancer |
Jiangsu HengRui Medicine Co., Ltd. |
2021-01-22 | PHASE3 |
| NCT02429687 | RECRUITING | Ovarian Germ Cell Cancer; Ovarian Neoplasms; Ovarian Cancer |
Beihua Kong |
2015-04 | PHASE3 |
| NCT04432714 | RECRUITING | DLBCL; Untreated; MYC Gene Rearrangement |
The First Affiliated Hospital with Nanjing Medical University |
2020-06-09 | PHASE1; PHASE2 |
| NCT05517213 | COMPLETED | Multiple Myeloma |
Affiliated Hospital to Academy of Military Medical Sciences |
2022-09-01 | |
| NCT05458180 | UNKNOWN | Peripheral T-cell Lymphoma |
Tianjin Medical University Cancer Institute and Hospital |
2022-07-07 | PHASE1 |
| NCT02794571 | COMPLETED | Advanced/Metastatic Tumors |
Genentech, Inc. |
2016-05-23 | PHASE1 |
| NCT04880746 | UNKNOWN | Peripheral T-cell Lymphoma |
Ruijin Hospital |
2020-10-17 | PHASE3 |
| NCT03220022 | ACTIVE_NOT_RECRUITING | AIDS-Related Lymphoma; Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma |
National Cancer Institute (NCI) |
2018-03-16 | PHASE1 |
| NCT04047862 | COMPLETED | Locally Advanced and Metastatic Solid Tumors |
BeiGene |
2019-08-15 | PHASE1 |
| NCT02964013 | COMPLETED | Neoplasms |
Merck Sharp & Dohme LLC |
2016-12-13 | PHASE1 |
| NCT03850067 | COMPLETED | Small Cell Lung Carcinoma |
Celgene |
2019-03-12 | PHASE1 |
| NCT05338541 | UNKNOWN | Neuroblastoma in Children |
Yizhuo Zhang |
2022-05-27 | PHASE1 |
| NCT03346096 | COMPLETED | Malignant Lymphoma |
Sheba Medical Center |
2018-10-09 | PHASE2 |
| NCT00878254 | COMPLETED | Mantle-Cell Lymphoma |
University of Miami |
2009-03-25 | PHASE2 |
| NCT05536154 | UNKNOWN | Lymphoma; Multiple Myeloma |
The Affiliated People's Hospital of Ningbo University |
2022-11-01 | |
| NCT05572476 | WITHDRAWN | Small Cell Lung Cancer; Platinum-Sensitive Lung Small Cell Carcinoma; Extensive-stage Small-cell Lung Cancer |
Institut Bergonié |
2023-10 | PHASE2 |
| NCT05510089 | UNKNOWN | Hematological Malignancy |
The Affiliated People's Hospital of Ningbo University |
2022-09-01 | |
| NCT04063163 | COMPLETED | Extensive Stage Small Cell Lung Cancer |
Shanghai Henlius Biotech |
2019-09-12 | PHASE3 |
| NCT06393816 | Not yet recruiting | Large Cell Neuroendocrine Carcinoma of the Lung |
Centre Leon Berard|Groupe Français de Pneumo-Cancérologie |
2024-05 | Phase 2 |
| NCT06406465 | Not yet recruiting | Carcinoma Neuroendocrine|Tumor Neuroendocrine|Tumors Neuroendocrine|Neuroendocrine; Carcinoma|Small Cell; Receptors |
National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
2024-05-15 | Phase 2 |
| NCT05694416 | UNKNOWN | MGMT-Unmethylated Glioblastoma |
Zhongnan Hospital |
2023-02-01 | PHASE2 |
| NCT03723941 | COMPLETED | Adrenocortical Carcinoma |
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia |
2018-07-20 | PHASE3 |
| NCT01505569 | COMPLETED | Ewing's Family Tumors; Renal Tumors; Hepatoblastoma; Rhabdomyosarcoma; Soft Tissue Sarcoma; Primary Malignant Brain Neoplasms; Retinoblastoma; Medulloblastoma; Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET); Atypical Teratoid/Rhabdoid Tumor (AT/RT); CNS Tumors; Germ Cell Tumors |
Masonic Cancer Center, University of Minnesota |
2011-10-20 | |
| NCT04951115 | TERMINATED | Small-cell Lung Cancer |
Weill Medical College of Cornell University |
2021-07-12 | PHASE2 |
| NCT05784987 | UNKNOWN | Diffuse Large B-cell Lymphoma |
The First Affiliated Hospital with Nanjing Medical University |
2023-04-15 | |
| NCT04129710 | UNKNOWN | Recurrent/RefractoryPrimary Central Nervous System Lymphoma (PCNSL) |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2020-01-01 | PHASE2 |
| NCT04996771 | UNKNOWN | Small Cell Lung Carcinoma |
Sun Yat-sen University |
2021-11-09 | PHASE1; PHASE2 |
| NCT05116007 | COMPLETED | SCLC, Extensive Stage |
Akeso |
2021-03-29 | PHASE1 |
| NCT02705508 | UNKNOWN | Treatment Refusal |
Sun Yat-sen University |
2016-02 | PHASE2 |
| NCT02047578 | UNKNOWN | Acute Lymphoblastic Leukemia |
Seoul National University Hospital |
2014-02-05 | PHASE2 |
| NCT06086288 | Not yet recruiting | Merkel Cell Carcinoma |
Fondazione IRCCS Istituto Nazionale dei Tumori Milano |
2023-11 | Phase 2 |
| NCT04981899 | UNKNOWN | Hodgkin Lymphoma |
St. Petersburg State Pavlov Medical University |
2021-03-01 | PHASE1; PHASE2 |
| NCT04923776 | TERMINATED | Small-cell Lung Cancer |
Brian Henick, MD |
2021-09-20 | PHASE2 |
| NCT04870112 | TERMINATED | Non-Small Cell Lung Cancer; Small Cell Lung Cancer |
AstraZeneca |
2021-06-28 | PHASE1 |
| NCT04044222 | UNKNOWN | Classic Hodgkin's Lymphoma |
Innovent Biologics (Suzhou) Co. Ltd. |
2019-10-21 | PHASE3 |
| NCT02348216 | COMPLETED | Refractory Diffuse Large B Cell Lymphoma (DLBCL); Relapsed Diffuse Large B-Cell Lymphoma; Transformed Follicular Lymphoma (TFL); Primary Mediastinal B-cell Lymphoma (PMBCL); High Grade B-cell Lymphoma (HGBCL) |
Kite, A Gilead Company |
2015-04-21 | PHASE1; PHASE2 |
| NCT04028050 | COMPLETED | Small Cell Lung Carcinoma |
Hoffmann-La Roche |
2019-08-12 | PHASE3 |
| NCT03141359 | ACTIVE_NOT_RECRUITING | Lung Cancer Stage II; Lung Cancer Stage III; Non Small Cell Lung Cancer |
Wake Forest University Health Sciences |
2017-05-12 | PHASE2 |
| NCT04712903 | COMPLETED | Small Cell Lung Carcinoma Extensive Disease |
AstraZeneca |
2020-12-16 | PHASE3 |
| NCT04543890 | UNKNOWN | Small Cell Lung Cancer Limited Stage |
Zhejiang Cancer Hospital |
2018-05-01 | PHASE2 |
| NCT05245994 | UNKNOWN | Lung Cancer; Small Cell Lung Cancer; Durvalumab |
Li Zhang, MD |
2021-08-21 | PHASE2 |
| NCT04005716 | COMPLETED | Small Cell Lung Cancer |
BeiGene |
2019-07-22 | PHASE3 |
| NCT06105619 | ACTIVE_NOT_RECRUITING | Glioblastoma |
Beijing Pearl Biotechnology Limited Liability Company |
2018-10-08 | PHASE2; PHASE3 |
| NCT02372409 | TERMINATED | Glioma; Pilocytic Astrocytoma; Anaplastic Astrocytoma; Glioblastoma; Mixed Oligoastrocytoma; Mixed Glioma; Oligodendroglioma; Optic Glioma; Astrocytoma |
Washington University School of Medicine |
2015-08-14 | PHASE2 |
| NCT03840902 | TERMINATED | Non-small Cell Lung Cancer |
EMD Serono Research & Development Institute, Inc. |
2019-04-16 | PHASE2 |
| NCT05092412 | ACTIVE_NOT_RECRUITING | Lung Cancer; Extensive-stage Small-cell Lung Cancer; Durvalumab |
You Lu |
2022-03-02 | PHASE2 |
| NCT02385110 | COMPLETED | Leukemia |
M.D. Anderson Cancer Center |
2015-09-23 | PHASE2 |
| NCT04363255 | UNKNOWN | Small Cell Lung Carcinoma |
Taizhou Hospital |
2020-05-01 | PHASE2 |
| NCT03531281 | WITHDRAWN | Hematopoietic and Lymphoid Cell Neoplasm; Hematopoietic Cell Transplantation Recipient |
City of Hope Medical Center |
2018-12-30 | PHASE1 |
| NCT02661503 | UNKNOWN | Classical Hodgkin Lymphoma |
University of Cologne |
2016-07 | PHASE3 |
| NCT02636322 | COMPLETED | Diffuse Large B-Cell Lymphoma Unclassifiable |
M.D. Anderson Cancer Center |
2016-03-29 | PHASE2 |
| NCT03991884 | COMPLETED | Recurrent B Acute Lymphoblastic Leukemia; Recurrent B Lymphoblastic Lymphoma; Refractory B Acute Lymphoblastic Leukemia; Refractory B Lymphoblastic Lymphoma |
University of Washington |
2019-09-24 | PHASE1 |
| NCT04665765 | ACTIVE_NOT_RECRUITING | Diffuse Large B-Cell Lymphoma Unclassifiable; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Recurrent Transformed B-Cell Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Refractory Transformed B-Cell Non-Hodgkin Lymphoma |
City of Hope Medical Center |
2021-01-18 | PHASE2 |
| NCT04356690 | TERMINATED | COVID-19 |
Boston Medical Center |
2020-05-08 | PHASE2 |
| NCT03992911 | UNKNOWN | Neuroendocrine Carcinoma of the Bladder |
Peking University |
2019-06-19 | PHASE2; PHASE3 |
| NCT02553460 | ACTIVE_NOT_RECRUITING | Acute Lymphoblastic Leukemia |
St. Jude Children's Research Hospital |
2016-01-29 | PHASE1; PHASE2 |
| NCT04372927 | TERMINATED | Locally Advanced Lung Non-Small Cell Carcinoma; Stage III Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8; Stage IIIC Lung Cancer AJCC v8 |
University of Washington |
2021-12-10 | PHASE2 |
| NCT02905110 | COMPLETED | Brain Tumor Recurrent |
The University of Texas Health Science Center, Houston |
2017-10-12 | EARLY_PHASE1 |
| NCT02166463 | ACTIVE_NOT_RECRUITING | Ann Arbor Stage IIB Hodgkin Lymphoma; Ann Arbor Stage IIIB Hodgkin Lymphoma; Ann Arbor Stage IVA Hodgkin Lymphoma; Ann Arbor Stage IVB Hodgkin Lymphoma; Childhood Hodgkin Lymphoma; Classic Hodgkin Lymphoma |
National Cancer Institute (NCI) |
2015-03-19 | PHASE3 |
| NCT04631029 | COMPLETED | Extensive Stage Lung Small Cell Carcinoma; Malignant Solid Neoplasm; Metastatic Malignant Neoplasm in the Brain |
National Cancer Institute (NCI) |
2021-04-27 | PHASE1 |
| NCT04902885 | COMPLETED | Extensive-stage Small-cell Lung Cancer |
Jiangsu Simcere Pharmaceutical Co., Ltd. |
2021-05-25 | PHASE3 |
| NCT03504410 | TERMINATED | Relapsed/Refractory Acute Myeloid Leukemia |
Cornerstone Pharmaceuticals |
2018-11-12 | PHASE3 |
| NCT02628405 | UNKNOWN | Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma; Recurrent Transformed Non-Hodgkin Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma; Refractory Transformed Non-Hodgkin Lymphoma |
Academic and Community Cancer Research United |
2016-05-20 | PHASE1; PHASE2 |
| NCT04684017 | UNKNOWN | SCLC; Anlotinib |
Shanghai Chest Hospital |
2019-05-01 | PHASE2 |
| NCT02512926 | COMPLETED | Relapsed Solid Tumors; Refractory Solid Tumors; Relapsed Leukemia; Refractory Leukemia |
Stanford University |
2016-02-16 | PHASE1 |
| NCT03071822 | UNKNOWN | Peripheral T Cell Lymphoma |
The University of Hong Kong |
2017-02-24 | PHASE4 |
| NCT04189094 | UNKNOWN | Small Cell Lung Cancer Limited Stage |
Zhejiang Cancer Hospital |
2020-01-01 | PHASE2 |
| NCT04917250 | UNKNOWN | Extranodal NK/T-cell Lymphoma |
Beijing Tongren Hospital |
2020-03-20 | PHASE2 |
| NCT01013779 | COMPLETED | Merkel Cell Carcinoma |
Trans Tasman Radiation Oncology Group |
2009-12 | PHASE2 |
| NCT03564704 | UNKNOWN | Leukemia; Leukemia, Acute; Adult Lymphoblastic Lymphoma; Leukemia, Lymphoblastic; Leukemia, T Cell; Adult Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Lymphoblastic Leukemia |
Nanfang Hospital, Southern Medical University |
2016-02-14 | PHASE2; PHASE3 |
| NCT03349346 | WITHDRAWN | Diffuse Large B-Cell Lymphoma; Mediastinal B-cell Lymphoma |
Gilead Sciences |
2019-06 | PHASE1 |
| NCT03901378 | WITHDRAWN | Neuroendocrine Carcinoma; Large Cell Neuroendocrine Carcinoma of the Lung; High Grade Neuroendocrine Carcinoma, Any Site |
Ochsner Health System |
2019-10-02 | PHASE2 |
| NCT04675697 | UNKNOWN | Extensive-stage Small-cell Lung Cancer |
Xiangya Hospital of Central South University |
2019-01-24 | PHASE2 |
| NCT03901118 | COMPLETED | Ovarian Cancer |
Chipscreen Biosciences, Ltd. |
2019-07-01 | PHASE2 |
| NCT01511562 | ACTIVE_NOT_RECRUITING | Lymphoma |
Alliance for Clinical Trials in Oncology |
2012-09 | PHASE2 |
| NCT03385096 | UNKNOWN | Autologous Hematopoietic Stem Cell Transplantation; Conditioning; Multiple Myeloma |
Nanfang Hospital, Southern Medical University |
2018-01-02 | PHASE2; PHASE3 |
| NCT03781869 | UNKNOWN | Extensive-stage Small Cell Lung Cancer |
Third Military Medical University |
2018-12 | PHASE2 |
| NCT03700359 | UNKNOWN | Small Cell Lung Carcinoma |
The First Affiliated Hospital of Guangzhou Medical University |
2019-03-01 | PHASE2 |
| NCT02025881 | TERMINATED | High-risk Medulloblastoma |
Gustave Roussy, Cancer Campus, Grand Paris |
2013-09-14 | PHASE1; PHASE2 |
| NCT03617432 | UNKNOWN | Experimental Tumor |
Peking University |
2018-08-28 | PHASE2 |
| NCT01849783 | COMPLETED | Extramedullary Plasmacytoma; Isolated Plasmacytoma of Bone; Light Chain Deposition Disease; Primary Systemic Amyloidosis; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma |
Margarida Magalhaes-Silverman |
2013-04-04 | PHASE2 |
| NCT02580994 | COMPLETED | Small Cell Lung Cancer (SCLC) |
European Organisation for Research and Treatment of Cancer - EORTC |
2017-12-08 | PHASE2 |
| NCT03268889 | UNKNOWN | Peripheral T Cell Lymphoma |
The First Affiliated Hospital of Soochow University |
2017-06-15 | |
| NCT02029950 | COMPLETED | Acute Myeloid Leukemia; Chronic Myelomonocytic Leukemia-2; High Risk Myelodysplastic Syndrome; Myeloproliferative Neoplasm |
National Cancer Institute (NCI) |
2013-12-16 | PHASE1 |
| NCT00968760 | COMPLETED | Lymphoma; B-cell Lymphoma |
M.D. Anderson Cancer Center |
2011-06-20 | PHASE1 |
| NCT03161054 | COMPLETED | Aggressive Non-Hodgkin Lymphoma |
Fondazione Italiana Linfomi - ETS |
2017-09-12 | PHASE2 |
| NCT01356680 | COMPLETED | Hodgkin Lymphoma |
University of Cologne |
2012-01-13 | PHASE3 |
| NCT00591630 | COMPLETED | Diffuse Large Cell Lymphoma; Lymphoma |
M.D. Anderson Cancer Center |
2007-11-14 | PHASE2 |
| NCT02987244 | UNKNOWN | T Cell Non-Hodgkin's Lymphoma |
Peking Union Medical College Hospital |
2016-03 | PHASE1; PHASE2 |
| NCT03707847 | UNKNOWN | ALK-Positive Anaplastic Large Cell Lymphoma |
Mingzhi Zhang |
2018-10-01 | PHASE4 |
| NCT02099175 | UNKNOWN | Sinonasal Tumors |
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano |
2013-11 | PHASE2 |
| NCT03018626 | UNKNOWN | Lymphoma, Large B-Cell, Diffuse |
Nanfang Hospital, Southern Medical University |
2017-07-27 | PHASE3 |
| NCT02858804 | COMPLETED | Mantle Cell Lymphoma |
Institute of Hematology & Blood Diseases Hospital, China |
2016-01 | PHASE4 |
| NCT00569985 | COMPLETED | Lymphoma |
City of Hope Medical Center |
2007-06 | PHASE1 |
| NCT02934503 | TERMINATED | Small Cell Lung Cancer (SCLC) |
NYU Langone Health |
2017-01-23 | PHASE2 |
| NCT02819999 | TERMINATED | Small Cell Lung Cancer |
AbbVie |
2016-10 | PHASE1 |
| NCT02116959 | TERMINATED | Advanced Intra-Ocular Retinoblastoma; Retinoblastoma |
University of California, San Francisco |
2014-07-23 | PHASE1 |
| NCT02338518 | UNKNOWN | Stomach Neoplasms; Gastric Cancer |
Jinling Hospital, China |
2015-01-04 | PHASE3 |
| NCT03735446 | TERMINATED | Acute Myeloid Leukemia; Myelodysplastic Syndromes |
Dana-Farber Cancer Institute |
2019-01-18 | PHASE1 |
| NCT01966913 | UNKNOWN | Germ Cell Tumor |
Assistance Publique - Hôpitaux de Paris |
2012-04 | PHASE1; PHASE2 |
| NCT03432598 | COMPLETED | Locally Advanced Lung Cancer; Metastatic Lung Cancer |
BeiGene |
2017-08-24 | PHASE2 |
| NCT02768558 | TERMINATED | Non-Small Cell Lung Cancer |
RTOG Foundation, Inc. |
2016-10-17 | PHASE3 |
| NCT02686346 | COMPLETED | Hodgkin Disease |
The Lymphoma Academic Research Organisation |
2016-03 | PHASE1; PHASE2 |
| NCT00732498 | COMPLETED | Lymphoma |
University of Arizona |
2006-05-15 | PHASE2 |
| NCT02875457 | UNKNOWN | Small Cell Lung Cancer |
Third Military Medical University |
2016-09 | PHASE3 |
| NCT01458366 | COMPLETED | Non-Hodgkin's Lymphoma |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
2011-11-09 | PHASE1; PHASE2 |
| NCT01714908 | UNKNOWN | Non-small Cell Lung Cancer |
Jinming Yu |
2012-12-14 | PHASE2 |
| NCT00536601 | COMPLETED | Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Nasal Type Extranodal NK/T-cell Lymphoma; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Burkitt Lymphoma; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET); Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Peripheral T-cell Lymphoma; Plasma Cell Neoplasm; Primary Systemic Amyloidosis; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Grade III Lymphomatoid Granulomatosis; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Malignant Testicular Germ Cell Tumor; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Neuroblastoma; Recurrent Small Lymphocytic Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Multiple Myeloma; Regional Neuroblastoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific; Waldenström Macroglobulinemia |
Roswell Park Cancer Institute |
2006-06-29 | |
| NCT00554788 | COMPLETED | Extraocular Retinoblastoma |
Children's Oncology Group |
2008-05-06 | PHASE3 |
| NCT03188198 | UNKNOWN | Large B Cell Lymphoma |
Mansoura University |
2016-06-01 | PHASE2 |
| NCT00562978 | COMPLETED | Lymphoma |
City of Hope Medical Center |
2000-05-16 | PHASE1; PHASE2 |
| NCT00967369 | COMPLETED | Recurrent Classic Hodgkin Lymphoma; Refractory Classic Hodgkin Lymphoma |
M.D. Anderson Cancer Center |
2009-08-24 | PHASE2 |
| NCT02592876 | TERMINATED | Lymphoma, B-cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Follicular, Grade 3b; Follicular Lymphoma, Grade 3b |
Seagen Inc. |
2015-10 | PHASE2 |
| NCT01435018 | COMPLETED | HIV-1 Infection |
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections |
2013-10-01 | PHASE3 |
| NCT02626338 | COMPLETED | Relapsed/Refractory Acute Myeloid Leukemia (AML) |
Arog Pharmaceuticals, Inc. |
2016-02 | PHASE1; PHASE2 |
| NCT02867956 | COMPLETED | Ovarian Cancer |
Sun Yat-sen University |
2016-08-10 | PHASE2 |
| NCT02130869 | COMPLETED | Neuroblastoma; Lymphoma; High-risk Tumor |
St. Jude Children's Research Hospital |
2014-10-10 | PHASE1 |
| NCT00500890 | TERMINATED | Choroid Plexus Tumors |
M.D. Anderson Cancer Center |
2005-09-02 | PHASE3 |
| NCT02306291 | COMPLETED | Leukemia, Myeloid, Acute |
GlycoMimetics Incorporated |
2015-03 | PHASE1; PHASE2 |
| NCT02653196 | TERMINATED | Neuroepithelial Tumor; Solid Tumor; Allogeneic Hematopoietic Stem Cell Transplantation |
Montefiore Medical Center |
2015-09 | EARLY_PHASE1 |
| NCT02499770 | COMPLETED | Small Cell Lung Cancer |
G1 Therapeutics, Inc. |
2015-06-26 | PHASE1; PHASE2 |
| NCT01481272 | COMPLETED | Diffuse Large B Cell Lymphoma |
Polish Lymphoma Research Group |
2011-11 | PHASE2 |
| NCT01169636 | COMPLETED | Hodgkin's Lymphoma |
M.D. Anderson Cancer Center |
2011-01-31 | PHASE1; PHASE2 |
| NCT02219737 | COMPLETED | CD20 Positive; Recurrent Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma |
National Cancer Institute (NCI) |
2014-09-12 | PHASE1 |
| NCT02348450 | UNKNOWN | Small Cell Lung Cancer |
Guangdong Association of Clinical Trials |
2015-02 | PHASE4 |
| NCT01336933 | COMPLETED | Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Hepatosplenic T-cell Lymphoma; Peripheral T-cell Lymphoma |
University of Nebraska |
2011-07-06 | PHASE2 |
| NCT01642251 | COMPLETED | Extensive Stage Small Cell Lung Carcinoma; Large Cell Lung Carcinoma; Neuroendocrine Carcinoma; Small Cell Carcinoma; Stage IV Non-Small Cell Lung Cancer AJCC v7 |
National Cancer Institute (NCI) |
2012-09-28 | PHASE1; PHASE2 |
| NCT02208583 | UNKNOWN | Hormone Refractory Prostate Cancer |
Tianjin Medical University Cancer Institute and Hospital |
2014-06 | |
| NCT00887159 | COMPLETED | Extensive Stage Small Cell Lung Carcinoma; Recurrent Small Cell Lung Carcinoma |
National Cancer Institute (NCI) |
2009-07-16 | PHASE2 |
| NCT01193842 | COMPLETED | AIDS-Related Plasmablastic Lymphoma; AIDS-Related Primary Effusion Lymphoma; Ann Arbor Stage I Diffuse Large B-Cell Lymphoma; Ann Arbor Stage I Grade 3 Follicular Lymphoma; Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma; HIV Infection; Plasmablastic Lymphoma; Primary Effusion Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Grade 3 Follicular Lymphoma |
National Cancer Institute (NCI) |
2010-10-06 | PHASE1; PHASE2 |
| NCT00653068 | COMPLETED | Childhood Atypical Teratoid/Rhabdoid Tumor |
Children's Oncology Group |
2009-02-10 | PHASE3 |
| NCT01589159 | COMPLETED | Metastatic Breast Cancer |
Tao OUYANG |
2013-01 | PHASE2 |
| NCT00379340 | COMPLETED | Stage III Kidney Wilms Tumor; Stage IV Kidney Wilms Tumor |
Children's Oncology Group |
2007-04-30 | PHASE3 |
| NCT01055314 | COMPLETED | Adult Rhabdomyosarcoma; Childhood Alveolar Rhabdomyosarcoma; Childhood Embryonal Rhabdomyosarcoma; Metastatic Childhood Soft Tissue Sarcoma; Stage IV Adult Soft Tissue Sarcoma; Untreated Childhood Rhabdomyosarcoma |
National Cancer Institute (NCI) |
2010-01 | PHASE2 |
| NCT01887340 | UNKNOWN | Seminoma |
Gustave Roussy, Cancer Campus, Grand Paris |
2013-06 | PHASE2 |
| NCT00576979 | COMPLETED | Leukemia |
City of Hope Medical Center |
2008-03-04 | PHASE1; PHASE2 |
| NCT01900509 | COMPLETED | Hodgkin Lymphoma; Non-Hodgkin Lymphoma; Acute Leukemia |
St. Jude Children's Research Hospital |
2013-08 | PHASE1 |
| NCT00920153 | TERMINATED | Lymphoma |
French Innovative Leukemia Organisation |
2008-05 | PHASE3 |
| NCT00381680 | COMPLETED | B-cell Childhood Acute Lymphoblastic Leukemia; L1 Childhood Acute Lymphoblastic Leukemia; L2 Childhood Acute Lymphoblastic Leukemia; Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia |
Children's Oncology Group |
2007-03 | PHASE3 |
| NCT01132807 | COMPLETED | Lymphoma |
Alliance for Clinical Trials in Oncology |
2010-05 | PHASE2 |
| NCT00678327 | COMPLETED | Lymphoma |
University College, London |
2008-08-29 | PHASE3 |
| NCT01677949 | WITHDRAWN | Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia |
Masonic Cancer Center, University of Minnesota |
2013-12 | PHASE2 |
| NCT01501149 | UNKNOWN | Nasal and Nasal-type NK/T-cell Lymphoma |
Mingzhi Zhang |
2011-01 | PHASE4 |
| NCT01457040 | COMPLETED | Acute Lymphoblastic Leukemia; Stem Cell Transplantation, Hematopoietic |
Nanfang Hospital, Southern Medical University |
2011-10 | PHASE2; PHASE3 |
| NCT00470223 | ACTIVE_NOT_RECRUITING | Sarcoma |
UNICANCER |
2007-03 | PHASE3 |
| NCT01501136 | UNKNOWN | Nasal and Nasal-type NK/T-cell Lymphoma |
Mingzhi Zhang |
2011-01 | PHASE4 |
| NCT01946529 | COMPLETED | Desmoplastic Small Round Cell Tumor; Ewing Sarcoma of Bone or Soft Tissue; Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor |
St. Jude Children's Research Hospital |
2013-12-27 | PHASE2 |
| NCT00450801 | COMPLETED | Lymphoma |
University of Miami |
2004-04 | PHASE2 |
| NCT01555710 | UNKNOWN | Extensive-Stage Small Cell Lung Cancer |
Alaunos Therapeutics |
2012-05 | PHASE3 |
| NCT01331525 | COMPLETED | Extensive Stage Small Cell Lung Cancer |
University Hospital Southampton NHS Foundation Trust |
2011-06 | PHASE2 |
| NCT01904643 | TERMINATED | Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Recurrent Adult Acute Myeloid Leukemia |
Stanford University |
2014-02 | PHASE1 |
| NCT00352027 | COMPLETED | Hodgkin's Lymphoma |
St. Jude Children's Research Hospital |
2006-07-20 | PHASE2 |
| NCT01450761 | COMPLETED | Small Cell Lung Carcinoma |
Bristol-Myers Squibb |
2011-12-13 | PHASE3 |
| NCT00749723 | COMPLETED | Recurrent Brain Tumors; Supratentorial PNETs; Medulloblastomas; Ependymomas |
University Hospital, Bonn |
2006-02-01 | PHASE2; PHASE3 |
| NCT01959477 | COMPLETED | Adult Grade III Lymphomatoid Granulomatosis; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Childhood Burkitt Lymphoma; Childhood Diffuse Large Cell Lymphoma; Childhood Grade III Lymphomatoid Granulomatosis; Childhood Immunoblastic Large Cell Lymphoma; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Contiguous Stage II Adult Burkitt Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Noncutaneous Extranodal Lymphoma; Peripheral T-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Grade III Lymphomatoid Granulomatosis; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Hairy Cell Leukemia; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Hodgkin Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Adult T-cell Leukemia/Lymphoma; Stage I Childhood Anaplastic Large Cell Lymphoma; Stage I Childhood Hodgkin Lymphoma; Stage I Childhood Large Cell Lymphoma; Stage I Childhood Lymphoblastic Lymphoma; Stage I Childhood Small Noncleaved Cell Lymphoma; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Small Lymphocytic Lymphoma; Stage IA Mycosis Fungoides/Sezary Syndrome; Stage IB Mycosis Fungoides/Sezary Syndrome; Stage II Adult Hodgkin Lymphoma; Stage II Adult T-cell Leukemia/Lymphoma; Stage II Childhood Anaplastic Large Cell Lymphoma; Stage II Childhood Hodgkin Lymphoma; Stage II Childhood Large Cell Lymphoma; Stage II Childhood Lymphoblastic Lymphoma; Stage II Childhood Small Noncleaved Cell Lymphoma; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IIA Mycosis Fungoides/Sezary Syndrome; Stage IIB Mycosis Fungoides/Sezary Syndrome; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Adult T-cell Leukemia/Lymphoma; Stage III Childhood Anaplastic Large Cell Lymphoma; Stage III Childhood Hodgkin Lymphoma; Stage III Childhood Large Cell Lymphoma; Stage III Childhood Lymphoblastic Lymphoma; Stage III Childhood Small Noncleaved Cell Lymphoma; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Small Lymphocytic Lymphoma; Stage IIIA Mycosis Fungoides/Sezary Syndrome; Stage IIIB Mycosis Fungoides/Sezary Syndrome; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult T-cell Leukemia/Lymphoma; Stage IV Childhood Anaplastic Large Cell Lymphoma; Stage IV Childhood Hodgkin Lymphoma; Stage IV Childhood Large Cell Lymphoma; Stage IV Childhood Lymphoblastic Lymphoma; Stage IV Childhood Small Noncleaved Cell Lymphoma; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma; Stage IVA Mycosis Fungoides/Sezary Syndrome; Stage IVB Mycosis Fungoides/Sezary Syndrome; T-cell Large Granular Lymphocyte Leukemia; Testicular Lymphoma; Waldenström Macroglobulinemia |
Case Comprehensive Cancer Center |
2014-03 | EARLY_PHASE1 |
| NCT01238159 | COMPLETED | Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type |
Samsung Medical Center |
2010-08 | PHASE2 |
| NCT01178658 | UNKNOWN | Non-Hodgkin Lymphoma |
Seoul National University Hospital |
2010-07 | PHASE2 |
| NCT00598169 | COMPLETED | Lymphoma |
AIDS Malignancy Consortium |
2007-11 | PHASE1 |
| NCT01331590 | COMPLETED | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
Washington University School of Medicine |
2011-07 | EARLY_PHASE1 |
| NCT01746173 | TERMINATED | T-cell Non-Hodgkin Lymphoma |
Dana-Farber Cancer Institute |
2013-07 | PHASE2 |
| NCT00051311 | COMPLETED | Hematologic Neoplasms |
National Cancer Institute (NCI) |
2003-01-03 | PHASE2 |
| NCT01063439 | UNKNOWN | Non Hodgkin's Lymphoma |
Inje University |
2010-01 | PHASE2 |
| NCT00400946 | COMPLETED | Drug/Agent Toxicity by Tissue/Organ; Leukemia |
Dana-Farber Cancer Institute |
2005-04 | PHASE3 |
| NCT00334815 | ACTIVE_NOT_RECRUITING | Lung Adenocarcinoma; Lung Adenosquamous Carcinoma; Lung Large Cell Carcinoma; Lung Squamous Cell Carcinoma; Minimally Invasive Lung Adenocarcinoma; Stage IIIA Lung Non-Small Cell Cancer AJCC v7; Stage IIIB Lung Non-Small Cell Cancer AJCC v7 |
National Cancer Institute (NCI) |
2006-06-15 | PHASE2 |
| NCT01947062 | UNKNOWN | Lung Cancer; Squamous Cell Carcinoma of the Lung; Locally Advanced and Metastatic Squamous Cell Carcinoma of the Lung |
Swami Rama Cancer Hospital and Research Institute |
2013-10 | PHASE3 |
| NCT01492556 | UNKNOWN | Breast Cancer |
Chinese Academy of Medical Sciences |
2011-12 | PHASE2 |
| NCT01127009 | COMPLETED | Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Recurrent Adult Acute Myeloid Leukemia |
Case Comprehensive Cancer Center |
2010-07 | PHASE1 |
| NCT01000285 | COMPLETED | Leukemia-Lymphoma, Adult T-Cell |
Washington University School of Medicine |
2010-09 | PHASE1; PHASE2 |
| NCT00317408 | UNKNOWN | Lymphoma |
European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma |
2004-04 | |
| NCT01415765 | WITHDRAWN | Lymphoma, Diffuse Large-Cell B-cell; Diffuse, Large B-cell Lymphoma; Lymphoma, Diffuse Large-Cell; Large-Cell Lymphoma, Diffuse |
National Cancer Institute (NCI) |
2011-07-15 | PHASE1; PHASE2 |
| NCT01048827 | COMPLETED | Acute Myeloid Leukemia |
University of California, San Francisco |
2009-11 | PHASE1 |
| NCT00369317 | COMPLETED | Childhood Acute Basophilic Leukemia; Childhood Acute Eosinophilic Leukemia; Childhood Acute Erythroleukemia (M6); Childhood Acute Megakaryocytic Leukemia (M7); Childhood Acute Minimally Differentiated Myeloid Leukemia (M0); Childhood Acute Monoblastic Leukemia (M5a); Childhood Acute Monocytic Leukemia (M5b); Childhood Acute Myeloblastic Leukemia With Maturation (M2); Childhood Acute Myeloblastic Leukemia Without Maturation (M1); Childhood Acute Myelomonocytic Leukemia (M4); Childhood Myelodysplastic Syndromes; de Novo Myelodysplastic Syndromes; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes; Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies |
Children's Oncology Group |
2007-03 | PHASE3 |
| NCT00053352 | COMPLETED | Childhood Embryonal Tumor; Childhood Extracranial Germ Cell Tumor; Childhood Extragonadal Germ Cell Tumor; Childhood Malignant Ovarian Germ Cell Tumor; Childhood Malignant Testicular Germ Cell Tumor; Childhood Teratoma; Ovarian Embryonal Carcinoma; Ovarian Yolk Sac Tumor; Stage II Malignant Testicular Germ Cell Tumor; Stage IIA Ovarian Germ Cell Tumor; Stage IIB Ovarian Germ Cell Tumor; Stage IIC Ovarian Germ Cell Tumor; Stage III Malignant Testicular Germ Cell Tumor; Stage IIIA Ovarian Germ Cell Tumor; Stage IIIB Ovarian Germ Cell Tumor; Stage IIIC Ovarian Germ Cell Tumor; Testicular Choriocarcinoma and Yolk Sac Tumor; Testicular Embryonal Carcinoma |
Children's Oncology Group |
2003-11-03 | PHASE3 |
| NCT00372593 | COMPLETED | Leukemia |
Children's Oncology Group |
2006-08 | PHASE3 |
| NCT01197560 | COMPLETED | Diffuse Large B-cell Lymphoma |
Celgene |
2010-09-02 | PHASE2; PHASE3 |
| NCT01249430 | COMPLETED | Recurrent Adult Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia |
National Cancer Institute (NCI) |
2011-01-20 | PHASE1 |
| NCT00410423 | COMPLETED | Relapsed Acute Leukemia; Refractory Acute Leukemia |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
2006-01 | PHASE1; PHASE2 |
| NCT00020722 | TERMINATED | Breast Cancer |
Barbara Ann Karmanos Cancer Institute |
2007-08 | PHASE2 |
| NCT00513474 | COMPLETED | Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
Massachusetts General Hospital |
2008-01 | PHASE1 |
| NCT01025778 | COMPLETED | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia |
Lund University Hospital |
2009-12 | PHASE2 |
| NCT01242072 | UNKNOWN | Malignancy; Cancer; Non Small Cell Lung Cancer; Small Cell Lung Cancer; Testicular Cancer; Thymoma; Ovarian Cancer; Osteosarcoma |
Alaunos Therapeutics |
2010-11 | PHASE1 |
| NCT01230788 | TERMINATED | Leukemia; Acute Lymphoblastic Leukemia; ALL |
Emory University |
2010-09 | |
| NCT00539500 | TERMINATED | Neuroblastoma |
M.D. Anderson Cancer Center |
2007-10 | PHASE2; PHASE3 |
| NCT00927875 | COMPLETED | Small Cell Lung Carcinoma |
Bristol-Myers Squibb |
2010-02 | PHASE1 |
| NCT00666484 | COMPLETED | Lymphoma; Neurotoxicity |
University College, London |
2008-03 | PHASE2 |
| NCT00513162 | COMPLETED | Neuroectodermal Tumor; Brain Metastases; Advanced Cancer |
M.D. Anderson Cancer Center |
2007-07 | PHASE1 |
| NCT00255723 | COMPLETED | Lymphoma |
Memorial Sloan Kettering Cancer Center |
2004-04 | PHASE2 |
| NCT00109928 | COMPLETED | Lymphoma |
SWOG Cancer Research Network |
2005-09 | PHASE2 |
| NCT00439361 | COMPLETED | Hodgkin Lymphoma; Lymphoma |
M.D. Anderson Cancer Center |
2007-02 | PHASE1 |
| NCT01222572 | TERMINATED | Non-small Cell Lung Cancer; Lung Cancer; NSCLC |
Dana-Farber Cancer Institute |
2010-12 | PHASE1; PHASE2 |
| NCT00660504 | COMPLETED | Lung Cancer |
Marubeni Pharmaceuticals (Suzhou) Co., Ltd. |
2008-04 | PHASE3 |
| NCT00589563 | COMPLETED | Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Infection; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Precancerous Condition; Secondary Myelofibrosis; Small Intestine Cancer |
City of Hope Medical Center |
2007-05 | PHASE2 |
| NCT00430118 | COMPLETED | Leukemia |
University Hospital Schleswig-Holstein |
2000-07 | PHASE3 |
| NCT00433498 | COMPLETED | Lung Cancer |
University College, London |
2007-01 | PHASE3 |
| NCT00936156 | COMPLETED | Metastatic, Cerebral Primitive Neuroectodermal Tumors |
Gustave Roussy, Cancer Campus, Grand Paris |
2009-01 | PHASE2 |
| NCT00426101 | COMPLETED | Hemophagocytic Lymphohistiocytosis |
Karolinska University Hospital |
2004-01 | PHASE3 |
| NCT00020566 | UNKNOWN | Sarcoma |
University of Leicester |
2001-02 | PHASE3 |
| NCT01258634 | TERMINATED | Osteosarcoma; Lung Metastases |
University of Chicago |
2010-07 | PHASE1 |
| NCT00515138 | TERMINATED | Lymphoma, B-Cell |
University of California, San Francisco |
2007-05 | EARLY_PHASE1 |
| NCT00073918 | COMPLETED | Anaplastic Large Cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Splenic Marginal Zone Lymphoma; Waldenström Macroglobulinemia |
Fred Hutchinson Cancer Center |
1999-02 | PHASE2 |
| NCT00602771 | COMPLETED | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome; Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Secondary Acute Myeloid Leukemia; Untreated Adult Acute Myeloid Leukemia |
National Cancer Institute (NCI) |
2008-01 | PHASE2 |
| NCT00144989 | COMPLETED | Small-Cell-Lung Cancer |
Haruhiko Fukuda |
2002-09 | PHASE3 |
| NCT00054327 | COMPLETED | Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Case Comprehensive Cancer Center |
2000-11 | PHASE2 |
| NCT00002766 | COMPLETED | Leukemia; Lymphoma |
Memorial Sloan Kettering Cancer Center |
1996-03 | PHASE3 |
| NCT00151242 | COMPLETED | Acute Myeloid Leukemia |
University of Ulm |
2004-07 | PHASE2; PHASE3 |
| NCT00939653 | TERMINATED | Relapsed Acute Myelogenous Leukemia |
Therapeutic Advances in Childhood Leukemia Consortium |
2009-07-10 | PHASE2 |
| NCT01300793 | TERMINATED | Non-Hodgkin's Lymphoma; B-cell Lymphoma |
University of California, San Francisco |
2007-05 | PHASE1 |
| NCT00958022 | TERMINATED | Small Cell Lung Cancer |
Ahmad Tarhini |
2009-09 | PHASE1 |
| NCT00379457 | UNKNOWN | Sarcoma |
European Paediatric Soft Tissue Sarcoma Study Group |
2006-06 | PHASE3 |
| NCT00627354 | COMPLETED | Prostate Cancer |
Groupe D'Etude des Tumeurs Uro-Genitales |
2006-09 | PHASE2 |
| NCT00983944 | WITHDRAWN | Lymphoma |
Ohio State University Comprehensive Cancer Center |
2009-09 | PHASE2 |
| NCT00660036 | TERMINATED | Acute Myeloid Leukemia |
University of Pittsburgh |
2008-09 | PHASE1 |
| NCT00991133 | COMPLETED | Lymphoblastic Leukemia, Acute, Childhood |
Genzyme, a Sanofi Company |
2009-10 | PHASE1 |
| NCT00477035 | COMPLETED | Leukemia; Multiple Myeloma |
Sally Arai |
2006-05 | PHASE1 |
| NCT00774046 | COMPLETED | Myelodysplastic Syndrome; Acute Myeloid Leukemia |
University of Chicago |
2002-12 | PHASE2 |
| NCT00079105 | COMPLETED | Lymphoma |
Newcastle-upon-Tyne Hospitals NHS Trust |
2004-01 | PHASE2 |
| NCT00392886 | UNKNOWN | Brain and Central Nervous System Tumors |
Children's Hospital Los Angeles |
2004-03 | PHASE3 |
| NCT00477945 | COMPLETED | Non Hodgkin's Lymphoma |
Indiana University |
2007-05 | PHASE1 |
| NCT00334672 | UNKNOWN | Nonneoplastic Condition |
Children's Cancer and Leukaemia Group |
2006-03 | PHASE3 |
| NCT00616785 | UNKNOWN | Lung Cancer |
Yonsei University |
2007-06 | PHASE2 |
| NCT01494558 | COMPLETED | Non-Small Cell Lung Cancer |
Chinese Academy of Medical Sciences |
2007-05 | PHASE2; PHASE3 |
| NCT00807755 | TERMINATED | Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific |
University of California, Davis |
2009-03 | PHASE1 |
| NCT00601718 | COMPLETED | Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Mycosis Fungoides/Sezary Syndrome; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage II Mycosis Fungoides/Sezary Syndrome; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Waldenström Macroglobulinemia |
University of Washington |
2007-12 | PHASE1; PHASE2 |
| NCT00810017 | TERMINATED | HER-2 Positive Metastatic Breast Cancer |
Medstar Health Research Institute |
2009-02 | PHASE2 |
| NCT00788125 | TERMINATED | Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Kidney Cancer; Liver Cancer; Lymphoma; Neuroblastoma; Ovarian Cancer; Sarcoma; Testicular Germ Cell Tumor; Unspecified Childhood Solid Tumor, Protocol Specific |
City of Hope Medical Center |
2008-09-03 | PHASE1; PHASE2 |
| NCT00004054 | COMPLETED | Prostate Cancer |
Radiation Therapy Oncology Group |
2000-01 | PHASE3 |
| NCT00003631 | COMPLETED | Lymphoma |
Memorial Sloan Kettering Cancer Center |
1998-08 | PHASE2 |
| NCT00278278 | UNKNOWN | Brain and Central Nervous System Tumors |
German Society for Pediatric Oncology and Hematology GPOH gGmbH |
2003-09 | PHASE3 |
| NCT00791154 | TERMINATED | Lung Cancer; Small Cell Lung Cancer; Solid Tumors; Extensive-stage Small Cell Lung Cancer |
NantCell, Inc. |
2008-12-02 | PHASE1; PHASE2 |
| NCT00231582 | COMPLETED | Testicular Neoplasms |
Assistance Publique - Hôpitaux de Paris |
2004-09 | PHASE2 |
| NCT00354107 | TERMINATED | Anaplastic Large Cell Lymphoma; Recurrent Childhood Anaplastic Large Cell Lymphoma |
National Cancer Institute (NCI) |
2007-01 | PHASE1; PHASE2 |
| NCT01385891 | COMPLETED | Acute Leukemia |
Istituto Giannina Gaslini |
2008-08 | PHASE2; PHASE3 |
| NCT00881166 | COMPLETED | Malignant Disease |
Astex Pharmaceuticals, Inc. |
2007-11 | PHASE1 |
| NCT00071058 | COMPLETED | Adrenal Cortex Neoplasms |
National Cancer Institute (NCI) |
2003-10 | PHASE2 |
| NCT00621361 | COMPLETED | Lung Cancer |
AstraZeneca |
2008-02 | PHASE1 |
| NCT00349778 | COMPLETED | Multiple Myeloma |
Stanford University |
2006-08 | PHASE2 |
| NCT00047320 | COMPLETED | Brain Tumor; Central Nervous System Tumors; Childhood Germ Cell Tumor |
Children's Oncology Group |
2004-01 | PHASE2 |
| NCT00186342 | COMPLETED | Acute Disease; Myelodysplastic Syndromes; Leukemia, Myeloid, Chronic; Myeloproliferative Disorders; Blood and Marrow Transplant (BMT); Myelodysplastic Syndromes (MDS); Leukemia |
Stanford University |
1992-09 | |
| NCT00776373 | TERMINATED | ALL; Burkitt's Lymphoma; Lymphoblastic Leukemia; CML |
Abramson Cancer Center at Penn Medicine |
2007-01 | PHASE1; PHASE2 |
| NCT00191139 | COMPLETED | Non-small Cell Lung Cancer |
Eli Lilly and Company |
2003-03 | PHASE2 |
| NCT00136084 | COMPLETED | Leukemia, Myelocytic, Acute |
St. Jude Children's Research Hospital |
2002-08 | PHASE3 |
| NCT00417248 | TERMINATED | Non-Small Cell Lung Cancer |
Nasser Hanna, M.D. |
2007-06 | PHASE1; PHASE2 |
| NCT00072280 | TERMINATED | Sarcoma |
Children's Oncology Group |
2004-11 | PHASE2 |
| NCT00004128 | UNKNOWN | Leukemia |
European Organisation for Research and Treatment of Cancer - EORTC |
1999-09 | PHASE3 |
| NCT00544570 | COMPLETED | Lymphoma |
City of Hope Medical Center |
1998-04 | |
| NCT00401609 | COMPLETED | Small Cell Lung Cancer |
National Cancer Institute, Naples |
2000-11 | PHASE1; PHASE2 |
| NCT00003573 | COMPLETED | Brain Tumors; Central Nervous System Tumors |
Children's Oncology Group |
1998-11 | PHASE2 |
| NCT00004188 | COMPLETED | Neuroblastoma |
Children's Oncology Group |
2001-02 | PHASE3 |
| NCT00202800 | COMPLETED | Pancreatic Cancer |
Corewell Health West |
2002-03 | PHASE2 |
| NCT00049218 | COMPLETED | Lung Cancer |
H. Lee Moffitt Cancer Center and Research Institute |
2003-04 | PHASE1; PHASE2 |
| NCT00135135 | COMPLETED | Neuroblastoma |
St. Jude Children's Research Hospital |
2005-08 | PHASE2 |
| NCT00072527 | COMPLETED | Lung Cancer |
Alliance for Clinical Trials in Oncology |
2003-11 | PHASE2 |
| NCT00274807 | COMPLETED | Leukemia |
The Cleveland Clinic |
2001-06 | PHASE2 |
| NCT00066482 | COMPLETED | Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor |
Children's Oncology Group |
2004-07 | |
| NCT00058461 | TERMINATED | B-cell Childhood Acute Lymphoblastic Leukemia; Childhood Burkitt Lymphoma; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; L3 Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma |
National Cancer Institute (NCI) |
2003-11 | PHASE2 |
| NCT00002565 | COMPLETED | Lymphoma |
M.D. Anderson Cancer Center |
1994-05-25 | PHASE3 |
| NCT00061919 | COMPLETED | Lung Cancer |
University College, London |
2003-04 | PHASE3 |
| NCT00320359 | COMPLETED | Lung Cancer, Small Cell |
GlaxoSmithKline |
2002-08 | PHASE3 |
| NCT00193531 | COMPLETED | Neuroendocrine Carcinoma |
SCRI Development Innovations, LLC |
1998-12 | PHASE2 |
| NCT00053768 | COMPLETED | Lymphoma |
German High-Grade Non-Hodgkin's Lymphoma Study Group |
2002-04 | PHASE3 |
| NCT00020943 | COMPLETED | Lymphoma |
Alliance for Clinical Trials in Oncology |
2001-06 | PHASE2 |
| NCT00041327 | COMPLETED | Lymphoma |
AIDS Malignancy Consortium |
2002-10 | PHASE2 |
| NCT00002649 | COMPLETED | Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma |
National Cancer Institute (NCI) |
1995-05 | PHASE3 |
| NCT00006373 | COMPLETED | Lymphoma |
H. Lee Moffitt Cancer Center and Research Institute |
2000-02 | PHASE2 |
| NCT00006734 | COMPLETED | Sarcoma |
Children's Oncology Group |
2001-05 | PHASE3 |
| NCT00005792 | COMPLETED | Multiple Myeloma; Plasma Cell Neoplasm |
H. Lee Moffitt Cancer Center and Research Institute |
1998-06-02 | PHASE1 |
| NCT00086944 | COMPLETED | Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma |
National Cancer Institute (NCI) |
2004-05 | PHASE1; PHASE2 |
| NCT00083083 | UNKNOWN | Lung Cancer |
American College of Radiology Imaging Network |
2005-03 | PHASE2 |
| NCT00216125 | COMPLETED | Non-Small Cell Lung Cancer |
Nasser Hanna, M.D. |
2002-02 | PHASE3 |
| NCT00049569 | COMPLETED | L1 Childhood Acute Lymphoblastic Leukemia; L2 Childhood Acute Lymphoblastic Leukemia; Non-T, Non-B Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Lymphoblastic Leukemia; T-cell Childhood Acute Lymphoblastic Leukemia |
National Cancer Institute (NCI) |
2003-01 | |
| NCT00002912 | COMPLETED | Leukemia |
National Cancer Institute (NCI) |
1997-01 | PHASE1 |
| NCT00290953 | COMPLETED | Lung Cancer; Pulmonary Neoplasms; Small Cell Lung Cancer |
Sanofi |
2002-10 | PHASE2; PHASE3 |
| NCT00109031 | COMPLETED | Cancer; Lymphoma; Leukemia |
Swedish Orphan Biovitrum |
2005-01 | PHASE3 |
| NCT00416819 | COMPLETED | Brain and Central Nervous System Tumors; Lymphoma |
University of California, San Francisco |
2003-09 | |
| NCT00023998 | COMPLETED | Metastatic Osteosarcoma |
National Cancer Institute (NCI) |
2001-07 | PHASE2 |
| NCT00002982 | COMPLETED | Lymphoma |
Memorial Sloan Kettering Cancer Center |
1997-01 | PHASE2 |
| NCT00017368 | COMPLETED | Neuroblastoma |
Children's Oncology Group |
2001-04 | PHASE2 |
| NCT00002472 | COMPLETED | Brain and Central Nervous System Tumors; Pediatric Germ Cell Tumor; Extragonadal Germ Cell Tumor |
Mayo Clinic |
1991-03 | PHASE2 |
| NCT00003632 | COMPLETED | Lymphoma |
Memorial Sloan Kettering Cancer Center |
1998-09 | PHASE2 |
| NCT00042978 | COMPLETED | Extensive Stage Small Cell Lung Cancer; Recurrent Small Cell Lung Cancer |
National Cancer Institute (NCI) |
2003-04 | PHASE2 |
| NCT00002466 | COMPLETED | Kidney Cancer; Sarcoma |
Memorial Sloan Kettering Cancer Center |
1990-05 | PHASE2 |
| NCT00005090 | TERMINATED | Lymphoma |
SWOG Cancer Research Network |
2000-04 | PHASE3 |
| NCT00005802 | COMPLETED | Leukemia |
Fred Hutchinson Cancer Center |
1999-06 | PHASE1; PHASE2 |
| NCT00003727 | COMPLETED | Leukemia |
University of Maryland, Baltimore |
1999-03 | PHASE2 |
| NCT00007813 | COMPLETED | Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Liver Cancer; Neuroblastoma; Ovarian Cancer; Sarcoma; Testicular Germ Cell Tumor |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
1997-05-31 | PHASE1 |
| NCT00032019 | COMPLETED | Lymphoma |
Alliance for Clinical Trials in Oncology |
2002-02 | PHASE2 |
| NCT00003597 | COMPLETED | Cancer |
Children's Oncology Group |
1998-11 | PHASE1 |
| NCT00004110 | COMPLETED | Neuroblastoma |
Memorial Sloan Kettering Cancer Center |
1999-08 | PHASE2 |
| NCT00187122 | COMPLETED | Lymphoblastic Lymphoma |
St. Jude Children's Research Hospital |
1993-03 | |
| NCT00003812 | COMPLETED | Lung Cancer |
Alliance for Clinical Trials in Oncology |
1999-03 | PHASE2 |
| NCT00002550 | COMPLETED | Lung Cancer |
Radiation Therapy Oncology Group |
1994-03 | PHASE3 |
| NCT00002494 | COMPLETED | Leukemia; Lymphoma |
Alliance for Clinical Trials in Oncology |
1992-05 | PHASE2 |
| NCT00002868 | COMPLETED | Leukemia |
Eastern Cooperative Oncology Group |
1997-11-20 | PHASE3 |
| NCT00003309 | COMPLETED | Brain and Central Nervous System Tumors |
Eastern Cooperative Oncology Group |
1999-05-04 | PHASE2 |
| NCT00043927 | COMPLETED | Small Cell Lung Cancer |
GlaxoSmithKline |
2001-04 | PHASE3 |
| NCT00002657 | COMPLETED | Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm |
SWOG Cancer Research Network |
1995-05 | PHASE2 |
| NCT00004010 | COMPLETED | Lymphoma |
Children's Oncology Group |
1999-10 | PHASE2 |
| NCT00002943 | COMPLETED | Extragonadal Germ Cell Tumor; Ovarian Cancer; Testicular Germ Cell Tumor; Unspecified Adult Solid Tumor, Protocol Specific |
Wake Forest University Health Sciences |
1993-02 | PHASE2 |
| NCT00002478 | TERMINATED | Cervical Cancer; Ovarian Cancer |
Gynecologic Oncology Group |
1993-06 | PHASE2 |
| NCT00002757 | COMPLETED | Leukemia; Lymphoma |
Children's Oncology Group |
2001-06 | PHASE3 |
| NCT00005987 | TERMINATED | Multiple Myeloma and Plasma Cell Neoplasm |
Masonic Cancer Center, University of Minnesota |
2000-08 | PHASE2 |
| NCT00004061 | COMPLETED | Leukemia; Lymphoma; Oral Complications |
Memorial Sloan Kettering Cancer Center |
1999-05 | PHASE2 |
| NCT00005998 | WITHDRAWN | Lymphoma |
Masonic Cancer Center, University of Minnesota |
2000-01 | PHASE2 |
| NCT00006047 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
H. Lee Moffitt Cancer Center and Research Institute |
2000-06 | PHASE1 |
| NCT00006747 | COMPLETED | Graft Versus Host Disease; Lymphoma |
Alliance for Clinical Trials in Oncology |
2000-11 | PHASE2 |
| NCT00002471 | COMPLETED | Leukemia; Lymphoma |
Memorial Sloan Kettering Cancer Center |
1990-02 | PHASE2 |
| NCT00006054 | TERMINATED | Immunologic Deficiency Syndromes; Chediak-Higashi Syndrome; Common Variable Immunodeficiency; Graft Versus Host Disease; X-Linked Lymphoproliferative Syndrome; Familial Erythrophagocytic Lymphohistiocytosis; Hemophagocytic Lymphohistiocytosis; X-linked Agammaglobulinemia; Wiskott-Aldrich Syndrome; Chronic Granulomatous Disease; X-linked Hyper IgM Syndrome; Severe Combined Immunodeficiency; Leukocyte Adhesion Deficiency Syndrome; Virus-Associated Hemophagocytic Syndrome |
Fairview University Medical Center |
2000-03 | |
| NCT00003113 | TERMINATED | Lymphoma |
Case Comprehensive Cancer Center |
1997-07 | PHASE2 |
| NCT00003158 | COMPLETED | Lung Cancer |
SWOG Cancer Research Network |
1998-02 | PHASE2 |
| NCT00002941 | COMPLETED | Lymphoma |
Children's Oncology Group |
1998-04 | PHASE2 |
| NCT00002816 | COMPLETED | Leukemia |
Children's Oncology Group |
1996-12 | PHASE3 |
| NCT00005631 | COMPLETED | Lymphoma |
Memorial Sloan Kettering Cancer Center |
1999-11 | PHASE2 |
| NCT00003380 | TERMINATED | Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer |
Gynecologic Oncology Group |
1998-05 | PHASE1 |
| NCT00187005 | TERMINATED | Acute Lymphoblastic Leukemia |
St. Jude Children's Research Hospital |
1998-07 | PHASE3 |
| NCT00003114 | COMPLETED | Lymphoma |
Case Comprehensive Cancer Center |
1997-07 | PHASE2 |
| NCT00002610 | COMPLETED | Kidney Cancer |
Children's Oncology Group |
1996-01 | PHASE3 |
| NCT00005946 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
University of Maryland, Baltimore |
2000-10 | PHASE1 |
| NCT00003575 | COMPLETED | Lymphoma |
National Cancer Institute (NCI) |
1999-01 | PHASE2 |
| NCT00007852 | COMPLETED | Lymphoma |
University of Nebraska |
2000-09-01 | PHASE2 |
| NCT00002665 | COMPLETED | Leukemia; Neutropenia; Thrombocytopenia |
SWOG Cancer Research Network |
1995-07 | PHASE2 |
| NCT00002552 | COMPLETED | Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm |
Barbara Ann Karmanos Cancer Institute |
1993-10 | PHASE2 |
| NCT00003996 | COMPLETED | Brain and Central Nervous System Tumors |
Alliance for Clinical Trials in Oncology |
1999-05 | PHASE2 |
| NCT00006032 | TERMINATED | Breast Cancer |
H. Lee Moffitt Cancer Center and Research Institute |
2000-03 | PHASE2 |
| NCT00002961 | TERMINATED | Leukemia |
Children's Hospital of Philadelphia |
1995-10 | PHASE3 |
| NCT00003269 | COMPLETED | Breast Cancer; Drug/Agent Toxicity by Tissue/Organ; Lung Cancer; Lymphoma; Ovarian Cancer; Unspecified Adult Solid Tumor, Protocol Specific |
Scripps Health |
1998-02 | PHASE2 |
| NCT00002880 | COMPLETED | Lymphoma |
Alliance for Clinical Trials in Oncology |
1996-11 | PHASE2 |
| NCT00002642 | COMPLETED | Lung Cancer |
SWOG Cancer Research Network |
1995-04 | PHASE2 |
| NCT00003657 | COMPLETED | Bladder Cancer; Brain and Central Nervous System Tumors; Carcinoma of Unknown Primary; Extragonadal Germ Cell Tumor; Head and Neck Cancer; Kidney Cancer; Lung Cancer; Ovarian Cancer; Sarcoma; Testicular Germ Cell Tumor; Unspecified Adult Solid Tumor, Protocol Specific |
Dana-Farber Cancer Institute |
1998-07 | PHASE2 |
| NCT00002588 | COMPLETED | Leukemia |
Case Comprehensive Cancer Center |
1994-08 | PHASE1 |
| NCT00006669 | WITHDRAWN | Lymphoma |
Medstar Health Research Institute |
1999-09 | PHASE2 |
| NCT01134861 | COMPLETED | Lung Cancer |
Radiation Therapy Oncology Group |
1994-07 | PHASE3 |
| NCT00025428 | COMPLETED | Neuroblastoma |
Societe Internationale d'Oncologie Pediatrique |
2000-12 | PHASE3 |
| NCT00025441 | COMPLETED | Ovarian Cancer; Sarcoma; Small Intestine Cancer |
Societe Internationale d'Oncologie Pediatrique |
1998-11 | PHASE2 |
| NCT00004900 | COMPLETED | Breast Cancer |
Hackensack Meridian Health |
1999-10 | PHASE2 |
| NCT00002898 | COMPLETED | Childhood Malignant Fibrous Histiocytoma of Bone; Sarcoma |
Societe Internationale d'Oncologie Pediatrique |
1995-01 | PHASE3 |
| NCT00005823 | COMPLETED | Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
Leukemia Research Fund |
1998-12 | PHASE3 |
| NCT00025064 | UNKNOWN | Lymphoma |
Children's Cancer and Leukaemia Group |
2000-01 | PHASE2 |
| NCT00000660 | COMPLETED | Sarcoma, Kaposi; HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE1 | |
| NCT00002003 | COMPLETED | Lymphoma, Non-Hodgkin; HIV Infections |
Lederle Laboratories |
PHASE2 | |
| NCT00002481 | UNKNOWN | Lymphoma |
St. Luke's Medical Center |
1990-03 | PHASE2 |
| NCT00417053 | UNKNOWN | Neuroblastoma |
Children's Cancer and Leukaemia Group |
PHASE3 | |
| NCT00168896 | UNKNOWN | Small Cell Lung Cancer |
Charite University, Berlin, Germany |
2001-10 | PHASE2; PHASE3 |
| NCT00002701 | UNKNOWN | Leukemia |
European Organisation for Research and Treatment of Cancer - EORTC |
1995-10 | PHASE3 |
| NCT00293358 | COMPLETED | Brain and Central Nervous System Tumors |
Children's Cancer and Leukaemia Group |
1997-01 | PHASE3 |
| NCT00002531 | UNKNOWN | Leukemia |
Johann Wolfgang Goethe University Hospital |
1993-01 | PHASE2 |
| NCT00217503 | COMPLETED | Lymphoma |
National Cancer Institute (NCI) |
2005-07 | PHASE2 |
| NCT00003064 | UNKNOWN | Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer |
Herbert Irving Comprehensive Cancer Center |
1997-01 | PHASE1; PHASE2 |
| NCT00018954 | COMPLETED | Leukemia; Lymphoma |
National Institutes of Health Clinical Center (CC) |
1992-10 | PHASE2 |
| NCT00002926 | UNKNOWN | Leukemia; Myelodysplastic Syndromes |
European Organisation for Research and Treatment of Cancer - EORTC |
1996-12 | PHASE3 |
| NCT00080925 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
National Institutes of Health Clinical Center (CC) |
2004-02 | PHASE1 |
| NCT00003643 | UNKNOWN | Extragonadal Germ Cell Tumor; Teratoma; Testicular Germ Cell Tumor |
European Organisation for Research and Treatment of Cancer - EORTC |
1998-10 | PHASE2; PHASE3 |
| NCT00030719 | UNKNOWN | Neuroblastoma |
University of Leicester |
2001-12 | PHASE3 |
| NCT00004086 | UNKNOWN | Leukemia; Lymphoma |
Garden State Cancer Center at the Center for Molecular Medicine and Immunology |
1997-06 | PHASE1 |
| NCT00025623 | COMPLETED | Neuroblastoma |
European Infant Neuroblastoma Study Group - 1999 |
1999-07 | PHASE2 |
| NCT00006045 | UNKNOWN | Leukemia |
Facet Biotech |
2000-03 | PHASE3 |
| NCT00180791 | UNKNOWN | Medulloblastoma; Brain Tumors; Neuroectodermal Tumors, Primitive |
Gustave Roussy, Cancer Campus, Grand Paris |
2002-07 | PHASE2 |
| NCT00669812 | UNKNOWN | Lymphoma; Small Intestine Cancer |
Cancer Research UK |
2008-02 | PHASE2 |
| NCT00012311 | UNKNOWN | Breast Cancer |
Herbert Irving Comprehensive Cancer Center |
2000-01 | PHASE2 |
| NCT00003284 | UNKNOWN | Lung Cancer |
Herbert Irving Comprehensive Cancer Center |
1998-01 | PHASE2 |
| NCT00199147 | UNKNOWN | Acute Myeloid Leukemia |
Johann Wolfgang Goethe University Hospital |
2000-01 | PHASE4 |
| NCT00041210 | UNKNOWN | Lymphoma |
Mount Vernon Cancer Centre at Mount Vernon Hospital |
2001-10 | PHASE3 |
| NCT00002987 | UNKNOWN | Lymphoma |
Medical Research Council |
1997-01 | PHASE3 |
| NCT00365755 | COMPLETED | Neuroblastoma |
Children's Cancer and Leukaemia Group |
PHASE3 | |
| NCT00016887 | UNKNOWN | Lymphoma |
German Low Grade Lymphoma Study Group |
2000-12 | PHASE3 |
| NCT00003273 | WITHDRAWN | Brain and Central Nervous System Tumors; Neuroblastoma; Retinoblastoma; Sarcoma |
NYU Langone Health |
1997-11 | PHASE2 |
| NCT00003578 | UNKNOWN | Lymphoma |
Lymphoma Trials Office |
1993-01 | PHASE3 |
| NCT00276731 | UNKNOWN | Neuroblastoma |
Children's Cancer and Leukaemia Group |
1995-03 | PHASE3 |
| NCT00003243 | COMPLETED | Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
1998-01 | PHASE1 |
| NCT00025402 | UNKNOWN | Leukemia |
III. Medizinische Klinik Mannheim |
1997-07 | PHASE3 |
| NCT00025610 | COMPLETED | Neuroblastoma |
European Infant Neuroblastoma Study Group - 1999 |
1999-07 | PHASE2 |
| NCT00003602 | UNKNOWN | Leukemia; Myelodysplastic Syndromes |
Riverside Haematology Group |
1998-03 | PHASE3 |
| NCT00003583 | UNKNOWN | Drug/Agent Toxicity by Tissue/Organ; Lung Cancer; Radiation Toxicity |
University of Florida |
1997-06 | PHASE2 |
| NCT00286169 | TERMINATED | Small-cell Lung Cancer |
Sumitomo Pharma Co., Ltd. |
2006-04 | PHASE3 |
| NCT00187161 | COMPLETED | Non-Hodgkin Lymphoma; Acute Lymphoblastic Leukemia, Mature B-Cell |
St. Jude Children's Research Hospital |
1994-11 | PHASE2 |
| NCT00556127 | COMPLETED | Diffuse Large B-Cell Lymphoma; POOR PROGNOSIS |
Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie |
2002-06 | PHASE2 |
| NCT00001339 | COMPLETED | Adrenal Cortical Carcinoma |
National Cancer Institute (NCI) |
1993-08 | PHASE2 |
| NCT00312988 | COMPLETED | Ovarian Cancer |
North Eastern German Society of Gynaecological Oncology |
2000-01 | PHASE3 |
| NCT00003421 | COMPLETED | Lymphoma |
Medical Research Council |
1998-06 | PHASE3 |
| NCT00025649 | COMPLETED | Neuroblastoma |
European Infant Neuroblastoma Study Group - 1999 |
1999-07 | PHASE2 |
(data from https://clinicaltrials.gov, updated on 2025-11-28)
Check the
Etoposide
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
- Etoposide Mechanism of Action: Topoisomerase II Inhibition in Small Cell Lung Cancer Cell Research
- Etoposide: Selectivity & Specificity
- Etoposide Working Concentration | Cell Culture | Treatment
- Etoposide Solubility in DMSO
- Etoposide Stock Solution
- Etoposide Storage
- Etoposide Stability
- Etoposide Combination Database
- Etoposide Molecular Weight
- Etoposide SMILES
- Etoposide CAS Number
- Etoposide Chemical Structure (2D and 3D)
- Etoposide IC50 for Cell-based and Cell-free Assays
- Etoposide MedChemExpress (HY-13629)? Try a better option.
- Etoposide Tocris (1226)? Try a better option.
- Etoposide APExBIO (A1971)? Try a better option.
- Etoposide Cayman (12092)? Try a better option.
- Etoposide Sigma (341205)? Try a better option.
- Etoposide SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.